Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a difficult diagnosis and prognosis. In this regard, new and more reliable biomarkers for the disease are needed. We propose peripheral blood, and more specifically the Hematopoietic Stem and Progenitor Cells (HSPCs) as potential prognostic biomarkers in the SOD1G93A murine model of ALS. We accurately and serially studied three HSPCs, Hematopoietic Stem Cells (HSCs), Common Lymphoid Progenitors (CLPs) and Common Myeloid Progenitors (CMPs), in both control and SOD1G93A mice along the disease progression by RT-PCR and flow cytometry analysis. We found interesting differences for every HSPCs type in the transgenic mice compared to the control mice at every time point selected, as well as differences along the disease course. The results showed a maintained compensatory increase of HSCs along disease progression. However, the downregulated levels of CLPs and CMPs suggested an exit of these cell populations to the peripheral tissues, probably due to their supporting role to the damaged tissues. In addition, a positive correlation of the percentage of CLPs and CMPs with the longevity was found, as well as a positive correlation of HSCs and CMPs with motor function and weight, thus reinforcing the idea that HSPCs play a relevant role in the longevity of the SOD1G93A mice. Based on these results, both CLPs and CMPs could be considered prognostic biomarkers of longevity in this animal model, opening the door to future studies in human patients for their potential clinical use.
- Amyotrophic Lateral Sclerosis
- SOD1G93A murine model
- Hematopoietic Stem and Progenitor Cells
- serial blood monitoring
- Copyright © 2016, American Journal of Physiology-Cell Physiology